Chia Tai Enterprises International Ltd

03839

Company Profile

  • Business description

    Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segments include Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.

  • Contact

    16 Harcourt Road
    21st Floor, Far East Finance Centre
    Hong Kong
    HKG

    T: +852 25201601

    http://www.ctei.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    900

Stocks News & Analysis

stocks

We remove our Moat Rating from ASX listed share

Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks

Best sustainable companies to own in 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.
stocks

New data centre deal for ASX listed REIT

New parternship adds to a growing data centre pipeline in fiscal 2026.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,034.702.20-0.02%
CAC 408,195.2145.710.56%
DAX 4024,539.3448.930.20%
Dow JONES (US)48,382.39319.100.66%
FTSE 1009,951.1419.760.20%
HKSE26,343.675.200.02%
NASDAQ23,235.636.36-0.03%
Nikkei 22551,832.801,493.322.97%
NZX 50 Index13,587.2338.810.29%
S&P 5006,858.4712.970.19%
S&P/ASX 2008,728.602.600.03%
SSE Composite Index4,023.4254.581.38%

Market Movers